PubMed · 2000 · 22 citations · 6 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyCell DivisionCell Cycle PharmacologyCell-cycle DysregulationCyclin-dependent KinasesMitotic InhibitorsCdk InhibitorsCell Cycle InhibitionCell Cycle InhibitorsCyclin RegulationCyclin-dependent Kinase RegulationCyclinsG2/m TransitionMitotic Cyclins
Exposure of ME180 and A431 carcinoma cells to Ukrain (NSC-631570), a novel semisynthetic drug from Chelidonium majus L, results in cell growth inhibition which is concomitant with reversible G2/M cell cycle arrest and apoptosis at doses as low as 7 microM. In contrast, the same drug concentrations were not affective towards normal human keratinocytes. In order to investigate whether cell cycle control mechanisms are effected in response to Ukrain, we analyzed cell cycle distribution and levels of cyclins and cyclin-dependent kinases in drug treated carcinoma cells. We found alterations in levels of mitotic cyclins A and B1, and cyclin-dependent kinases CDK1 and CDK2, after treatment. We also observed an upregulation of CDK inhibitor p27 in both cancer cell lines which may lead to the G2/M cells accumulation.
6
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.
Y. Katayose, M Kim, Amol N.S. Rakkar et al. · PubMed · 1997 · 320 citations
Jun Chen, T Willingham, M Shuford et al. · Journal of Clinical Investigation · 1996 · 76 citations · Full text
Medicine, Cancer Biology, Oncology +17
Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
Andrejs Liepins, Nowicky Jw, Bustamante Jo et al. · PubMed · 1996 · 26 citations
Medicine, Oncology, Pharmacology +14
Cytostatic effect of TNFα on cancer cells is independent of p21WAF1
Masaaki Shiohara, Adrian F. Gombart, Jeffrey D Berman et al. · Oncogene · 1997 · 14 citations
Medicine, Cancer Biology, Oncology +14
Ukrain both as an anti cancer and immunoregulatory agent.
J W Nowicky, G Manolakis, Dirk Meijer et al. · PubMed · 1992 · 12 citations
Medicine, Oncology, Pharmacology +17